We are maintaining our Neutral recommendation on Theravance ( THRX ) with a target price of $28.00. The stock carries a Zacks #3 Rank (Hold rating) in the short run.
Read the original post:
Theravance Stays Neutral – Analyst Blog
We are maintaining our Neutral recommendation on Theravance ( THRX ) with a target price of $28.00. The stock carries a Zacks #3 Rank (Hold rating) in the short run.
Read the original post:
Theravance Stays Neutral – Analyst Blog